First the good news: Pfizer Inc. and Germany-based partner BioNTech SE said updated trial data for their omicron BA.4/BA.5-adapted bivalent booster showed a “substantially higher” immune response in adults than Read more
Tag: medical treatments
Moderna stock falls after earnings miss by a wide margin and company cuts sales outlook by up to $3 billion
Moderna Inc. shares moved lower Thursday, after the COVID vaccine maker posted far weaker-than-expected third-quarter earnings and lowered full-year sales guidance by up to $3 billion. The stock was last Read more
Weekly tally of COVID cases and deaths continues to fall; Moderna lowers vaccine-sales outlook by as much as $3 billion
The global tally of COVID-19 cases fell 17% in the week through Oct. 30 from the previous week, while the death toll fell 5%, the World Health Organization said in Read more
Weekly tally of COVID cases and deaths continues to fall; Moderna lowers vaccine-sales outlook by as much as $3 billion
The global tally of COVID-19 cases fell 17% in the week through Oct. 30 from the previous week, while the death toll fell 5%, the World Health Organization said in Read more
Lilly’s new diabetes drug doubled sales expectations. It may also be used to treat obesity
Eli Lilly & Co. Inc.’s LLY, -2.57% steady transformation into a developer of both cutting-edge diabetes and obesity treatments is well underway. The drugmaker said Tuesday that sales of Mounjaro, Read more
Hospitalizations on the rise in New York City as new COVID strains spread rapidly
Hospitalizations are rising again in New York City with the spread of new COVID-19 subvariants that are better at evading immunity. Cases of flu and respiratory syncytial virus, or RSV, Read more
Hospitalizations on the rise in New York City as new COVID strains spread rapidly
Hospitalizations are rising again in New York City with the spread of new COVID-19 subvariants that are better at evading immunity. Cases of flu and respiratory syncytial virus, or RSV, Read more
Wall Street is being nicer on earnings as vaccine makers, fintech reports near
With a downcast earnings season passing the halfway mark, results from financial-technology and vaccine makers will arrive this week amid questions about consumer spending and demand for COVID-19 drugs. As Read more
Dialysis company DaVita stock suffering worst day in 22 years after big profit miss, disappointing outlook
Shares of DaVita Inc. plummeted in active trading Friday, toward their worst performance in more than two decades, after the dialysis company reported third-quarter that fell well below expectations and Read more
Sanofi posts higher sales but $2.07 billion net profit misses forecasts
Sanofi SA on Friday posted higher sales for the third quarter, though net profit declined slightly, and raised its business earnings-per-share guidance for 2022, citing a good performance in vaccines Read more